Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1584651
Reference Type
Journal Article
Title
Contamination of nanoparticles by endotoxin: evaluation of different test methods
Author(s)
Smulders, S; Kaiser, JP; Zuin, S; Van Landuyt, KL; Golanski, L; Vanoirbeek, J; Wick, P; Hoet, PH
Year
2012
Is Peer Reviewed?
1
Journal
Particle and Fibre Toxicology
EISSN:
1743-8977
Volume
9
Page Numbers
41
Language
English
PMID
23140310
DOI
10.1186/1743-8977-9-41
Web of Science Id
WOS:000314264300001
Abstract
BACKGROUND:
Nanomaterials can be contaminated with endotoxin (lipopolysaccharides, LPS) during production or handling. In this study, we searched for a convenient in vitro method to evaluate endotoxin contamination in nanoparticle samples. We assessed the reliability of the commonly used limulus amebocyte lysate (LAL) assay and an alternative method based on toll-like receptor (TLR) 4 reporter cells when applied with particles (TiO(2), Ag, CaCO(3) and SiO(2)), or after extraction of the endotoxin as described in the ISO norm 29701.
RESULTS:
Our results indicate that the gel clot LAL assay is easily disturbed in the presence of nanoparticles; and that the endotoxin extraction protocol is not suitable at high particle concentrations. The chromogenic-based LAL endotoxin detection systems (chromogenic LAL assay and Endosafe-PTS), and the TLR4 reporter cells were not significantly perturbed.
CONCLUSION:
We demonstrated that nanoparticles can interfere with endotoxin detection systems indicating that a convenient test method must be chosen before assessing endotoxin contamination in nanoparticle samples.
Keywords
Endotoxin; Nanoparticles; LAL assay; TLR4 reporter cells
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity